Showing 1 - 6 results of 6 for search 'Changbin Zhu', query time: 0.07s Refine Results
  1. 1
    An in-depth exploration of four heterogeneity structure-based EGFR mutation subgroups in Chinese non-small cell lung cancer

    An in-depth exploration of four heterogeneity structure-based EGFR mutation subgroups in Chinese non-small cell lung cancer by Yongfeng Yu, Fei Yao, Jin Wang, Zhan Huang, Tao Hu, Changbin Zhu, Shun Lu

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Molecular subtyping of endometrial cancer via a simplified one-step NGS classifier, ARID1A and ZFHX4 mutations help further subclassify CNL/MSI-H patients

    Molecular subtyping of endometrial cancer via a simplified one-step NGS classifier, ARID1A and ZFHX4 mutations help further subclassify CNL/MSI-H patients by Qiuli Teng, Zeng Yuan, Yulong Mu, Xinyue Ma, Shuaixin Wang, Chenggong Sun, Linhan Chin, Zhan Huang, Changbin Zhu, Aijun Yin, Ruifen Dong

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study

    Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small c... by Mengqing Xie, Minwei Bao, Xiaorong Dong, Lin Wu, Li Liu, Jing Zhao, Xiangling Chu, Yan Wu, Xianxiu Ji, Yujia Fang, Xin Yu, Shiji Zhang, Qi Wang, Tao Hu, Jin Wang, Changbin Zhu, Chunxia Su

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Immune microenvironment heterogeneity characterizes biologically distinct KRASmut/SPOPmut and KRASmut/PIK3CAmut mesonephric-like adenocarcinoma subtypes revealed by integrated whole-exome and transcriptomic profiling

    Immune microenvironment heterogeneity characterizes biologically distinct KRASmut/SPOPmut and KRASmut/PIK3CAmut mesonephric-like adenocarcinoma subtypes revealed by integrated whol... by Jing Zeng, Jing Zeng, Qingli Li, Qingli Li, Kemin Li, Kemin Li, Lu Yang, Lu Yang, Lian Xu, Lian Xu, Wei Wang, Wei Wang, Kaixuan Yang, Kaixuan Yang, Qingbo Wei, Jin Wang, Changbin Zhu, Rutie Yin, Rutie Yin

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Tumor microenvironment biomarkers predicting pathological response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma: post-hoc analysis of a single center, phase 2 study

    Tumor microenvironment biomarkers predicting pathological response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma: post-hoc analysis of a... by Qian Li, Tingting Feng, Jing Zhu, Chang Yu, Ying Yang, Qixun Chen, Dan Su, Xiaotian Zhang, Changbin Zhu, Rui Zhu, Tingting Lu, Liwei Xu, Lisha Ying, Canming Wang, Weiming Xu, Jinchao Wang, Minran Huang, Chenyang Xu, Jiaoyue Jin

    Published 2024-08-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysis

    Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast can... by Xiaoxiao Liu, Chunying Zhuang, Lei Liu, Ling Xiong, Xin Xie, Ping He, Juanjuan Li, Bing Wei, Xi Yan, Tinglun Tian, Xiaorong Zhong, Jie Chen, Yan Cheng, Dan Zheng, Peng Cheng, Tianlin Sun, Weiwei Li, Changbin Zhu, Shuaitong Chen, Chao Fang, Jun Fu, Shibao Li, Jing Jing, Ting Luo

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: